ES394319A1 - Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre. - Google Patents

Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre.

Info

Publication number
ES394319A1
ES394319A1 ES394319A ES394319A ES394319A1 ES 394319 A1 ES394319 A1 ES 394319A1 ES 394319 A ES394319 A ES 394319A ES 394319 A ES394319 A ES 394319A ES 394319 A1 ES394319 A1 ES 394319A1
Authority
ES
Spain
Prior art keywords
triiodothyronine
thyroxine
compositions
hypertriglyceridemias
hypercholesterolemias
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES394319A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES394319A1 publication Critical patent/ES394319A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES394319A 1971-05-28 1971-08-18 Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre. Expired ES394319A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712126533 DE2126533A1 (de) 1971-05-28 1971-05-28 Verfahren zur Herstellung pharma zeutischer Zubereitungen

Publications (1)

Publication Number Publication Date
ES394319A1 true ES394319A1 (es) 1975-04-01

Family

ID=5809169

Family Applications (1)

Application Number Title Priority Date Filing Date
ES394319A Expired ES394319A1 (es) 1971-05-28 1971-08-18 Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre.

Country Status (13)

Country Link
US (1) US3917832A (enExample)
AT (1) AT306228B (enExample)
AU (1) AU3450471A (enExample)
BE (1) BE773121A (enExample)
BR (1) BR7105898D0 (enExample)
DE (1) DE2126533A1 (enExample)
ES (1) ES394319A1 (enExample)
FR (1) FR2139787B1 (enExample)
GB (1) GB1296510A (enExample)
HU (1) HU162454B (enExample)
IL (1) IL37640A (enExample)
NL (1) NL7111198A (enExample)
ZA (1) ZA715734B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401891D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
EP1565171A4 (en) * 2002-11-05 2010-06-30 Shire Llc PROGRESSIVE ABSORPTION OF MIXED FORMULATIONS OF THYROID HORMONES
EP2148660A2 (en) * 2007-04-23 2010-02-03 Diurnal Ltd Sustained release
US20100292281A1 (en) * 2009-05-15 2010-11-18 The University Of Kentucky Research Foundation Treatment of mci and alzheimer's disease
US9968574B2 (en) * 2009-05-15 2018-05-15 The University Of Kentucky Research Foundation Treatment of MCI and Alzheimer's disease
CN102984938A (zh) * 2010-05-13 2013-03-20 肯塔基大学研究基金会 轻度认知障碍(mci)和阿尔茨海默氏症的治疗方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2925364A (en) * 1957-08-12 1960-02-16 Baxter Laboratories Inc Method of treating hypercholesterol-emia with d-thyroxine
US3157574A (en) * 1959-05-01 1964-11-17 Smith Kline French Lab Method of reducing cholesterol levels

Also Published As

Publication number Publication date
AT306228B (de) 1973-03-26
FR2139787B1 (enExample) 1974-09-06
FR2139787A1 (enExample) 1973-01-12
AU3450471A (en) 1973-04-19
IL37640A0 (en) 1971-12-29
US3917832A (en) 1975-11-04
IL37640A (en) 1974-10-22
GB1296510A (enExample) 1972-11-15
NL7111198A (enExample) 1972-11-30
DE2126533A1 (de) 1972-12-14
BR7105898D0 (pt) 1973-05-10
HU162454B (enExample) 1973-02-28
ZA715734B (en) 1973-04-25
BE773121A (fr) 1972-03-27

Similar Documents

Publication Publication Date Title
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
PH15268A (en) 2,2-methylenediphenols,its composition and use
ZA72345B (en) Polymerization compositions and processes
JPS5293767A (en) Novel oxazolidone derivatives and preparation thereof
IT948362B (it) Impianto di macinazione e mescola zione
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
IL39694A0 (en) The use of certain pyrazolylbenzimidazoles as fungicides and bactericides
IL39110A (en) Sulphamides,their preparation and pharmaceutical compositions containing them
ES394319A1 (es) Procedimiento de obtencion de composiciones para reducir elnivel de colesterina y lipidos en la sangre.
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
AU4775772A (en) Compositions and processes
IL48790A0 (en) Novel hydroxy-pyrimidines,their preparation and pharmaceutical compositions containing them
ZA722077B (en) Veterinary and pharmaceutical compositions
CA1005273A (en) Photographic products, processes and compositions
GB1401612A (en) 2,4-diamino-5-benzylpyrimidines and preparations thereof
GB1372721A (en) Containers of antiseptics for the treatment of burns and scalds
AU4191572A (en) Improvements in or relating tothe processing of calcium carbonates
ZA721937B (en) Pharmaceutical preparations and uses thereof
CA947528A (en) Manure processing and improved treatment materials
ZA729148B (en) Thiazolotriazolyphosphonothioates,preparation and uses thereof
AU4453472A (en) Self-shining treatment substances
IL41373A (en) Alpha-d-4-dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane theobromineacetate,its preparation and pharmaceutical compositions containing it
KE2621A (en) Pharmaceutical preparation and treatment
ZA721486B (en) Zirconium flame-resist treatment
IL40585A0 (en) New blood sugar-sinking sulphonyl-aminopyrimidines,processes for the preparation thereof and pharmaceutical compositions containing the same